Key Highlights

● COR closed at $323.59 on 9 October 2026, and the $372.07 consensus target implies upside of about 15.0 per cent.

● The consensus draws on 16 analysts, with targets from $285 to $440, while the second data set shows a $369.25 mean from 14 analysts.

● Market data reports 13 Buy and three Hold ratings with no Sell, a Moderate Buy consensus.

● Leerink Partners raised its target to $388 from $380 on 7 October, and Wells Fargo, JPMorgan, UBS and Morgan Stanley raised targets in August.

Cencora, Inc. (NYSE:COR) closed at $323.59 on Friday 9 October 2026. The company is part of the S&P 500, and the consensus analyst target sits about 15% above the share price.

What Is the Latest Analyst Price Target?

Market data puts the average analyst price target for Cencora at $372.07, based on 16 analysts with ratings in the past 12 months. Against the $323.59 close, the consensus target suggests implied upside of about 15.0 per cent. The targets range from $285 to $440.

The second data set, using third-party data, shows a mean of $369.25 and a median of $365, with a high of $430 and a low of $330 across 14 analysts. Its price targets were last updated on 4 September 2026, and its quoted price of $316.37 relates to 6 October, so its upside percentages are not directly comparable with those above. The two averages are close, and both sit within the range of recent named broker targets.

What Are Wall Street Analysts Saying?

Market data reports 13 Buy, 3 Hold and no Sell ratings, a consensus of Moderate Buy. The second data set lists 7 Strong Buy, 4 Buy and 3 Hold for September 2026.

Recent broker actions on market data include Leerink Partners raising its target from $380 to $388 with an Outperform rating on 7 October 2026. Royal Bank of Canada reiterated Sector Perform with a $330 target on 8 September. In August, Wells Fargo raised its target from $331 to $395, JPMorgan from $382 to $390, UBS from $412 to $430 and Morgan Stanley from $342 to $346, all with positive ratings. Robert W. Baird set a $370 target and Evercore reiterated Outperform at $350. Just outside the three-month window, Barclays lowered its target from $425 to $350 in June.

What Could Help the Stock Reach the Price Target?

Market data says the latest quarter delivered earnings per share of $4.48 against a $4.35 consensus, on revenue of $84.75 billion against $84.31 billion expected. If the company keeps meeting or beating expectations, and if brokers continue to nudge targets higher as several did in August and October, the distance between the share price and the consensus target could narrow.

What Could Prevent the Stock Reaching the Target?

The recent run of target increases is encouraging, but views vary. Royal Bank of Canada holds a Sector Perform rating with a target close to the current share price, and the lowest target of $285 sits below it. Barclays' June reduction shows that targets can move down as well as up. Wider risks for any large company include shifts in market sentiment, changes in sector valuations and results falling short of expectations.

What Should Investors Watch Next?

Investors may also follow further broker target changes, any update to company guidance, and how the consensus figures at each provider develop.

Cencora's Run of Target Increases Meets a Few Targets Near the Price

Cencora closed at $323.59 on 9 October 2026, with the $372.07 consensus target about 15.0 per cent higher and the second data set's $369.25 mean close behind. Recent named targets from $330 to $430 are consistent with both, and increases from Leerink, Wells Fargo, JPMorgan, UBS and Morgan Stanley are encouraging, but RBC holds Sector Perform near the share price and market data's lowest target of $285 sits below it. Barclays' June cut from $425 to $350 shows that targets can move down as well as up.